Matthew Streicher

Mr. Matthew Streicher

Cleveland Clinic, Cleveland, Georgia, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
EBElise I. Baron
Elise I. Baron
MKMandy Miller Koop
Mandy Miller Koop
MSMatthew Streicher
Matthew Streicher
ARAnson Rosenfeldt
Anson Rosenfeldt
JAJay Lance Alberts
Jay Lance Alberts

4 March 2022 in Sensors
Verified
Journal Article
Open access
PDF file
MKMandy Miller Koop
Mandy Miller Koop
ARAnson Rosenfeldt
Anson Rosenfeldt
KOKelsey Owen
Kelsey Owen
APAmanda L. Penko
Amanda L. Penko
MSMatthew Streicher
Matthew Streicher
JAJay Lance Alberts
Jay Lance Alberts
Augmented-reality (AR) headsets, such as the Microsoft HoloLens 2 (HL2), have the potential to be the next generation of wearable technology as they provide interactive digital stimuli in the context of ecologically-valid daily activities while containing inertial measurement units (IMUs) to objectively quantify the movements of the user. A necessary precursor to the widespread utilization of the HL2 in the fields of movement science and rehabilitation is the rigorous validation of its capacity to generate biomechanical outcomes comparable to gold standard outcomes. This project sought to determine equivalency of kinematic outcomes characterizing lower-extremity function derived from the HL2 and three-dimensional (3D) motion capture systems (MoCap). Sixty-six healthy adults completed two lower-extremity tasks while kinematic data were collected from the HL2 and MoCap: (1) continuous walking and (2) timed up-and-go (TUG). For all the continuous walking metrics (cumulative distance, time, number of steps, step and stride length, and velocity), equivalence testing indicated that the HL2 and MoCap were statistically equivalent (error ≤ 5%). The TUG metrics, including turn duration and turn velocity, were also statistically equivalent between the two systems. The accurate quantification of gait and turning using a wearable such as the HL2 provides initial evidence for its use as a platform for the development and delivery of gait and mobility assessments, including the in-person and remote delivery of highly salient digital movement assessments and rehabilitation protocols.

19 July 2023 in Neurorehabilitation and Neural Repair
Verified
Journal Article
Closed access
JAJay L. Alberts
Jay L. Alberts
RKRyan D Kaya
Ryan D Kaya
APAmanda L. Penko
Amanda L. Penko
MSMatthew Streicher
Matthew Streicher
EZEric M. Zimmerman
Eric M. Zimmerman
ARAnson B. Rosenfeldt
Anson B. Rosenfeldt
Background: Postural instability and gait dysfunction (PIGD) is a cardinal symptom of Parkinson’s disease (PD) and is exacerbated under dual-task conditions. Dual-task training (DTT), enhances gait performance, however it is time and cost intensive. Digitizing DTT via the Dual-task Augmented Reality Treatment (DART) platform can expand the availability of an effective intervention to address PIGD. Objective: The aim of this project was to evaluate DART in the treatment of PIGD in people with PD compared to a Traditional DTT intervention. It was hypothesized that both groups would exhibit significant improvements in gait, and the improvements for the DART group would be non-inferior to Traditional DTT. Methods: A single-blind randomized controlled trial was conducted with 47 PD participants with PIGD. Both groups completed 16 therapeutic sessions over 8 weeks; the DART platform delivered DTT via the Microsoft HoloLens2. Primary outcomes included clinical ratings and single- and dual-task gait biomechanical outcomes. Results: Clinical measures of PD symptoms remained stable for DART and Traditional DTT groups. However, both groups exhibited a significant increase in gait velocity, cadence, and step length during single- and multiple dual-task conditions following the interventions. Improvements in gait velocity in the DART group were non-inferior to Traditional DTT under the majority of conditions. Conclusion: Non-inferior improvements in gait parameters across groups provides evidence of the DART platform being an effective digital therapeutic capable of improving PIGD. Effective digital delivery of DTT has the potential to increase use and accessibility to a promising, yet underutilized and difficult to administer, intervention for PIGD. Clinical Trial Registration: ClinicalTrials.gov Dual-task Augmented Reality Treatment for Parkinson’s Disease (DART) NCT04634331; posted November 18, 2020.

1 October 2020 in IEEE Transactions on Human-Machine Systems
Verified
Journal Article
Closed access
MKMandy Miller Koop
Mandy Miller Koop
ARAnson Rosenfeldt
Anson Rosenfeldt
JJJoshua D. Johnston
Joshua D. Johnston
MSMatthew Streicher
Matthew Streicher
JQJingan Qu
Jingan Qu
JAJay Lance Alberts
Jay Lance Alberts
Biomechanical measures are the gold standard in the assessment of gait in healthy and chronic disease populations. Augmented reality (AR) systems represent an opportunity to evaluate human movement under more realistic and interactive conditions. A barrier to integrating AR into healthcare is the unknown accuracy of systems in the quantification of human movement. This project aimed to determine the accuracy of the HoloLens relative to three-dimensional motion capture (MoCap) in quantifying gait. Ten healthy adults completed nine walking trials (n = 3 for slow, medium, and fast speed, respectively). Outcome measures included: cumulative walking distance, number of steps, step length, and speed. Statistical equivalence testing, using an a priori threshold of five percent, confirmed biomechanical measures derived from the HoloLens was equivalent to MoCap. Cumulative walking distance from the HoloLens was within 1.5–2.1% of the MoCap system for all walking speeds. Difference between systems in terms of movement accuracy was less than 3.7 cm across trials. Equivalence in outcomes makes the HoloLens appropriate for the quantification of frequently used gait variables to characterize walking performance. Future AR applications have the potential to deliver digital therapeutics to patient populations under more real-world conditions and monitor performance using objective and quantitative outcomes.

1 June 2020 in Ophthalmology Retina
Verified
Journal Article
Closed access
ARAleksandra Rachitskaya
Aleksandra Rachitskaya
AYAlex Yuan
Alex Yuan
SDSara Davidson
Sara Davidson
MSMatthew Streicher
Matthew Streicher
MDMeghan DeBenedictis
Meghan DeBenedictis
JAJay Alberts
Jay Alberts

14 October 2022 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
SLSusan M. Linder
Susan M. Linder
EBElise Baron
Elise Baron
KLKen Learman
Ken Learman
MKMandy Miller Koop
Mandy Miller Koop
DEDebbie Espy
Debbie Espy
JAJay Lance Alberts
Jay Lance Alberts